Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa
- PMID: 37820114
- DOI: 10.1097/OLQ.0000000000001877
Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates From the Eastern Cape Province in South Africa
Abstract
Background: There is a paucity of Neisseria gonorrhoeae antimicrobial resistance data from resource-constrained settings because of the lack of diagnostic testing and limited scale of surveillance programs. This study aimed to determine the antimicrobial resistance profile of N. gonorrhoeae in the rural Eastern Cape province of South Africa.
Methods: Specimens for N. gonorrhoeae culture were obtained from men with urethral discharge and women with vaginal discharge attending primary health care facilities. Direct inoculation of the agar plates was performed followed by culture and drug susceptibility testing using the Etest at the laboratory. Whole-genome sequencing of the isolates was performed to identify resistance-determining variants.
Results: One hundred N. gonorrhoeae isolates were obtained. Most strains were nonsusceptible to ciprofloxacin (76%), tetracycline (75%), and penicillin G (72%). The gyrA S91F mutation was present in 68 of 72 ciprofloxacin-resistant isolates (94%), with concurrent parC mutations in 47 of 68 (69%); gyrA I250M was the only mutation in 4 other resistant strains. One azithromycin-resistant isolate was identified with a minimal inhibitory concentration (MIC) of 8.0 mg/L and the 23S rDNA gene mutation C2597T. The median MIC of cefixime was 0.016 mg/L (range, 0.016-0.064 mg/L), and that of ceftriaxone was 0.016 mg/L (range, 0.016 mg/L). Whole-genome sequencing showed 58 sequence types as revealed in N. gonorrhoeae sequence typing for antimicrobial resistance and 70 sequence types in N. gonorrhoeae multiantigen sequence typing.
Conclusions: This study confirmed high rates of N. gonorrhoeae antimicrobial resistance to ciprofloxacin, penicillin G, and tetracycline in our setting. The MICs of cephalosporins are reassuring for ceftriaxone use in syndromic treatment regimens, but the identification of azithromycin resistance warrants further attention.
Copyright © 2023 American Sexually Transmitted Diseases Association. All rights reserved.
Conflict of interest statement
Conflict of Interest and Sources of Funding: None of the authors declare a conflict of interest. This study was funded by the South African Medical Research Council through a grant awarded to the Global Antibiotic Research and Development Partnership (GARDP) under the project “Evaluating antimicrobial resistance of Neisseria gonorrhoeae infection in population groups at high risk of STI acquisition” (SAMRC project code 96150).
References
-
- Kularatne RS, Niit R, Rowley J, et al. Adult gonorrhoea, chlamydia and syphilis prevalence, incidence, treatment, and syndromic case reporting in South Africa: Estimates using the Spectrum-STI model, 1990–2017. PLoS One 2018; 13:e0205863.
-
- Wi TE, Ndowa FJ, Ferreyra C, et al. Diagnosing sexually transmitted infections in resource-constrained settings: Challenges and way forward. J Int AIDS Soc 2019; 22(Suppl 6):e25343.
-
- Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: Past, evolution, and future. Clin Microbiol Rev 2014; 27:587–613.
-
- Lewis DA, Sriruttan C, Muller EE, et al. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother 2013; 68:1267–1270.
-
- Maduna LD, Kock MM, van der Veer BMJW, et al. Antimicrobial resistance of Neisseria gonorrhoeae isolates from high-risk men in Johannesburg, South Africa. Antimicrob Agents Chemother 2020; 64:e00906–e00920.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical